Caplin Point Laboratories Ltd (CAPLIPOINT)


πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 2203.00
% Change: 1.29% (Prev Close: 2175.00)

Volume: 64,216
% Change: -26.15% (Prev Volume: 86,955)

Delivery: 34,094
Delivery % : 53.09
% Change: -15.19% (Prev Delivery: 40,202)

Turnover: 1,413 Lacs
% Change: -25.56% (Prev Turnover: 1,898)

πŸ’Ή EOD Valuation

P/E Ratio: 29.63
P/B Ratio: 5.87
Market Cap: 16743 Rs. Cr.


Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: CAPLIPOINT
Market Cap: 15952 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 2641.00
52 Week Low: 1551.05

All-Time High: 2641.00 Rs.
All-Time Low: 1.05 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
10.42% | 3.23% | 11.23% | 9.76% | 40.75%


πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 70.56%

Change (3Y | 1Y): 1.68% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 6.16%

Change (3Y | 1Y): 4.13% | 0.43%

DII Holding

DII Holding: 2.22%

Change (3Y | 1Y): 1.10% | 0.22%

Public Holding: 21.06%


🏦 Financial Strength

Debt to Equity: 0.00
Debt: 5.02 Rs. Cr.

Book Value: 375.01 Rs.
Current Ratio: 6.97
Interest Coverage: 956.20
Free Cash Flow: 240.85 Rs. Cr.


πŸ“ˆ Growth & Sales

Sales Growth: 13.14%

Sales Growth Qtr (YOY | QoQ):
11.17% | 1.55%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
17.55% | 15.14% | 13.14%


πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 18.32%

Profit Growth Qtr (YOY | QoQ):
23.26% | 3.77%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
20.49% | 21.49% | 18.32%


EPS Rs.

EPS (TTM): 74.35 Rs.

EPS Qtr (Last Year | Latest):
16.31 Rs. | 20.10 Rs.

EPS Annual (Last Annual | Annual March):
60.19 Rs. | 70.56 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
20.37% | 21.37%


Net Profit Rs. Cr.

Net Profit (TTM): 566.92 Rs. Cr.

Net Profit (Annual - March): 541.09 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
124.92| 145.28 | 150.76


EBITDA Rs. Cr.

EBITDA (Quarter): 200.93 Rs. Cr.
EBITDA (Previous Yr Ql): 170.39 Rs. Cr.

EBITDA (Annual - March): 743.35 Rs. Cr.
EBITDA (Previous Annual): 617.27 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
20.18% | 19.79%


πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 33.83%

OPM Qtr (Previous | Current):
33.45% | 34.84%

OPM Annual (5 Yrs | Last Yr | March):
31.84% | 32.60% | 33.39%


Return on Equity %

ROE: 21.67%

ROE (5 Yrs | 3 Yrs | Last Yr):
24.22% | 23.49% | 24.23%


Return on Capital Employed %

ROCE: 25.85%

ROCE (5 Yrs | 3 Yrs | Last Yr):
26.95% | 26.21% | 26.46%


Return on Assets %

ROA (TTM): 18.32%

ROA (5 Yrs | 3 Yrs | Last Yr):
19.19% | 18.76% | 18.83%



PEG Ratio: 1.31
Dividend Yield: 0.29%

PE 3 Yrs: 23.25
PE 5 Yrs: 20.68

Dividend Yield: 0.29%


πŸ‘₯ Company

Caplin Point Laboratories Ltd

CAPLIPOINT

Promoter Holding: %